Sex differences in symptoms following the administration of BNT162b2 mRNA COVID-19 vaccine in children below 5 years of age in Germany (CoVacU5): a retrospective cohort study
Sex differences exist in post-vaccination symptoms after BNT162b2 administration even in young children. These are of importance for the conception of approval studies, for post-vaccination monitoring and for future vaccination strategies (German Clinical Trials Register ID: DRKS00028759).
Authors
- Wolfgang von Meißner (ORCID: https://orcid.org/0000-0002-2380-4699)
- Nicole Toepfner (ORCID: https://orcid.org/0000-0002-9693-4419)
- Reinhard Berner (ORCID: https://orcid.org/0000-0002-6216-9173)
- Jeanne Moor (ORCID: https://orcid.org/0000-0001-8286-618X)
- Christoph Strumann (ORCID: https://orcid.org/0000-0003-2725-6543)
- Cho-Ming Chao
- Matthias B. Moor (ORCID: https://orcid.org/0000-0002-7717-651X)
- Karolina Kublickiene (ORCID: https://orcid.org/0000-0002-4841-6836)
Institutions
- Karolinska Institutet (SE)
- European University of Applied Sciences (DE)
- Helios Universitätsklinikum Wuppertal (DE)
- Universities of Giessen and Marburg Lung Center (DE)
- Cardio-Pulmonary Institute (DE)
- University Hospital Carl Gustav Carus (DE)
- University of Rostock (DE)
- Technische Universität Dresden (DE)
Publication Details
- Journal
- Biology of Sex Differences
- Published
- 2024-09-26
- DOI
- https://doi.org/10.1186/s13293-024-00651-x
- Citations
- 1
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.39